Yue Sui

543 total citations · 1 hit paper
22 papers, 382 citations indexed

About

Yue Sui is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Yue Sui has authored 22 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Pharmacology and 4 papers in Immunology. Recurrent topics in Yue Sui's work include Pharmacological Effects of Natural Compounds (6 papers), Ginseng Biological Effects and Applications (2 papers) and Fibroblast Growth Factor Research (2 papers). Yue Sui is often cited by papers focused on Pharmacological Effects of Natural Compounds (6 papers), Ginseng Biological Effects and Applications (2 papers) and Fibroblast Growth Factor Research (2 papers). Yue Sui collaborates with scholars based in China, Hong Kong and Macao. Yue Sui's co-authors include Jianming Wu, Jianping Chen, Saixing Zeng, Hanyang Ma, Han Lin, Liangyan Wang, Jianping Chen, Kumar Ganesan, Qingqing Liu and Hailin Tang and has published in prestigious journals such as Annals of Oncology, Frontiers in Microbiology and Advanced Science.

In The Last Decade

Yue Sui

20 papers receiving 381 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway

2024 70 citations Kumar Ganesan, Cong Xu et al. Science China Life Sciences profile →

Peers

Yue Sui

ONCOL

MSOR

Weilin Chen China

Meiling Tang China

Changchun Zhu China

Jisun Lee South Korea

Joel Hedlund Sweden

Wedad Saeed Al-Qahtani Saudi Arabia

Weilin Chen China

Yue Sui

364 ×2.2

166 ×3.0

ONCOL

27 ×0.6

72 ×1.8

12 ×0.3

MSOR

Citations per year, relative to Yue Sui Yue Sui (= 1×) peers Weilin Chen

Countries citing papers authored by Yue Sui

Since Specialization

Citations

This map shows the geographic impact of Yue Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Sui more than expected).

Fields of papers citing papers by Yue Sui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Sui. The network helps show where Yue Sui may publish in the future.

Co-authorship network of co-authors of Yue Sui

This figure shows the co-authorship network connecting the top 25 collaborators of Yue Sui. A scholar is included among the top collaborators of Yue Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue Sui. Yue Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Qingqing, Yue Sui, Jacky W. Y. Lam, et al.. (2025). Strategic Design of Aptamer‐Guided Aggregation‐Induced Emission Nanoparticles for Targeted Photodynamic Therapy in Breast Cancer. Advanced Science. 12(43). e03358–e03358.

Fan, Rui, et al.. (2025). The next viral pandemic—where do we stand?. Folia Microbiologica. 70(3). 505–516.

Li, Chen, et al.. (2025). Apelin‐13 Protects Against Myocardial Hypoxia/Reoxygenation (H/R) Injury by Inhibiting Ferroptosis Via Nrf2 Activation. Journal of Biochemical and Molecular Toxicology. 39(4). e70223–e70223. 1 indexed citations

Ganesan, Kumar, Cong Xu, Yue Sui, et al.. (2024). Cryoprotective isoliquiritigenin-zein phosphatidylcholine nanoparticles inhibits breast cancer-bone metastasis by targeting JAK-STAT signaling pathways. Chemico-Biological Interactions. 396. 111037–111037. 5 indexed citations

Ganesan, Kumar, Fei Gao, Chuan Zheng, et al.. (2024). Isoliquiritigenin-infused electrospun nanofiber inhibits breast cancer proliferation and invasion through downregulation of PI3K/Akt/mTOR and MMP2/9 pathways. Journal of Drug Delivery Science and Technology. 96. 105609–105609. 5 indexed citations

Ganesan, Kumar, Cong Xu, Yue Sui, et al.. (2024). Ononin Inhibits Tumor Bone Metastasis and Osteoclastogenesis By Targeting Mitogen-Activated Protein Kinase Pathway in Breast Cancer. Research. 7. 553–553. 13 indexed citations

Sui, Yue, Qingqing Liu, Cong Xu, et al.. (2024). Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21. Cell Death and Disease. 15(1). 67–67. 3 indexed citations

Ganesan, Kumar, Cong Xu, Jianming Wu, et al.. (2024). Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway. Science China Life Sciences. 67(9). 1849–1866. 70 indexed citations breakdown →

Xu, Cong, Chen Zhang, Kumar Ganesan, et al.. (2023). Anti-migratory Properties of Cryoprotective Isoliquiritigenin-zein Phosphatidylcholine Nanoparticles Prevent Triple-negative Breast Cancer through PI3K-mTOR and MMP2/9 Pathways. Current Medicinal Chemistry. 32(9). 1770–1788. 18 indexed citations

10.

Qin, Songbing, Wei Tian, Mingqiang Li, et al.. (2023). 1054P A phase Ia study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of a modular CLDN18.2-targeting PG CAR-T therapy (IBI345) in patients with CLDN18.2+ solid tumors. Annals of Oncology. 34. S638–S638. 5 indexed citations

11.

Ganesan, Kumar, et al.. (2023). Unraveling the Role of Hepatic PGC1α in Breast Cancer Invasion: A New Target for Therapeutic Intervention?. Cells. 12(18). 2311–2311. 2 indexed citations

12.

Yin, Yifeng, et al.. (2023). Influence of Gegenqinlian decoction on pharmacokinetics and pharmacodynamics of saxagliptin in type 2 diabetes mellitus rats. Biopharmaceutics & Drug Disposition. 44(6). 396–405. 1 indexed citations

13.

Sui, Yue & Jianping Chen. (2022). Hepatic FGF21: Its Emerging Role in Inter-Organ Crosstalk and Cancers. International Journal of Biological Sciences. 18(15). 5928–5942. 18 indexed citations

14.

Yin, Yifeng, et al.. (2021). Influence of Gegenqinlian Decoction on Pharmacokinetics and Pharmacodynamics of Atorvastatin Calcium in Hyperlipidemic Rats. European Journal of Drug Metabolism and Pharmacokinetics. 47(1). 117–126. 7 indexed citations

15.

Sui, Yue, Jianming Wu, & Jianping Chen. (2021). The Role of Gut Microbial β-Glucuronidase in Estrogen Reactivation and Breast Cancer. Frontiers in Cell and Developmental Biology. 9. 631552–631552. 96 indexed citations

16.

Zhang, Tong, et al.. (2021). A NFT verification method for distributed AI system. Journal of Physics Conference Series. 2132(1). 12017–12017. 4 indexed citations

17.

Sui, Yue, et al.. (2019). Preparation and magnetic properties of anisotropic Nd2Fe14B/Sm2Co17 hybrid-bonded magnets. Journal of Rare Earths. 37(10). 1047–1052. 7 indexed citations

18.

Peng, Yunfeng, et al.. (2019). Is “going green” good to all? Evidence from South Korea. Human and Ecological Risk Assessment An International Journal. 26(5). 1188–1206. 4 indexed citations

19.

Lin, Han, Yue Sui, Hanyang Ma, Liangyan Wang, & Saixing Zeng. (2018). CEO Narcissism, Public Concern, and Megaproject Social Responsibility: Moderated Mediating Examination. Journal of Management in Engineering. 34(4). 72 indexed citations

20.

Shi, Chao, Chunhong Yan, Yue Sui, et al.. (2017). Thymoquinone Inhibits Virulence Related Traits of Cronobacter sakazakii ATCC 29544 and Has Anti-biofilm Formation Potential. Frontiers in Microbiology. 8. 2220–2220. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weilin Chen Breakdown of academic impact, for papers by Meiling Tang Breakdown of academic impact, for papers by Changchun Zhu Breakdown of academic impact, for papers by Jisun Lee Breakdown of academic impact, for papers by Joel Hedlund Breakdown of academic impact, for papers by Wedad Saeed Al-Qahtani